UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 212

Sortiert nach

Long-term therapy with elexacaftor/tezacaftor/ivacaftor (ETI) in cystic fibrosis: improved clinical outcomes but infection and inflammation persist

The European respiratory journal, 2023-08, Vol.62 (2), p.2301008

2023

Volltextzugriff (PDF)

The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations

PloS one, 2012-09, Vol.7 (9), p.e45001

2012

Volltextzugriff (PDF)

Comparison of microbiomes from different niches of upper and lower airways in children and adolescents with cystic fibrosis

PloS one, 2015-01, Vol.10 (1), p.e0116029-e0116029

2015

Volltextzugriff (PDF)

Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis

The Lancet (British edition), 2014-08, Vol.384 (9944), p.703-713

2014

Volltextzugriff (PDF)

Fusobacterium nucleatum: a novel immune modulator in breast cancer?

Expert reviews in molecular medicine, 2023-04, Vol.25, p.e15-e15, Article e15

2023

Volltextzugriff (PDF)

Anaerobic bacteria cultured from cystic fibrosis airways correlate to milder disease: a multisite study

The European respiratory journal, 2018-07, Vol.52 (1), p.1800242-1800242

2018

Volltextzugriff (PDF)

Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease

PloS one, 2016-03, Vol.11 (3), p.e0149998-e0149998

2016

Volltextzugriff (PDF)

Reduced bacterial colony count of anaerobic bacteria is associated with a worsening in lung clearance index and inflammation in cystic fibrosis

PloS one, 2015-05, Vol.10 (5), p.e0126980-e0126980

2015

Volltextzugriff (PDF)

Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations

PloS one, 2013-04, Vol.8 (4), p.e62917-e62917

2013

Volltextzugriff (PDF)

Characterization of Bacteria Using Surface-Enhanced Raman Spectroscopy (SERS): Influence of Microbiological Factors on the SERS Spectra

Analytical chemistry (Washington), 2022-07, Vol.94 (26), p.9327-9335

2022

Volltextzugriff (PDF)

The Role of Short-Chain Fatty Acids, Produced by Anaerobic Bacteria, in the Cystic Fibrosis Airway

American journal of respiratory and critical care medicine, 2015-12, Vol.192 (11), p.1314-1324

2015

Volltextzugriff (PDF)

Lung function and microbiota diversity in cystic fibrosis

Microbiome, 2020-04, Vol.8 (1), p.45-45, Article 45

2020

Volltextzugriff (PDF)

Electronic cigarette vapour increases virulence and inflammatory potential of respiratory pathogens

Respiratory research, 2019-12, Vol.20 (1), p.267-10, Article 267

2019

Volltextzugriff (PDF)

Lung Microbiota and Bacterial Abundance in Patients with Bronchiectasis when Clinically Stable and during Exacerbation

American journal of respiratory and critical care medicine, 2013-05, Vol.187 (10), p.1118-1126

2013

Volltextzugriff (PDF)

Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo

PloS one, 2011-10, Vol.6 (10), p.e26525

2011

Volltextzugriff (PDF)

Investigation of the effect of type 2 diabetes mellitus on subgingival plaque microbiota by high-throughput 16S rDNA pyrosequencing

PloS one, 2013-04, Vol.8 (4), p.e61516-e61516

2013

Volltextzugriff (PDF)

Impact of the CFTR-potentiator ivacaftor on airway microbiota in cystic fibrosis patients carrying a G551D mutation

PloS one, 2015-04, Vol.10 (4), p.e0124124-e0124124

2015

Volltextzugriff (PDF)

Significance of anaerobes and oral bacteria in community-acquired pneumonia

PloS one, 2013-05, Vol.8 (5), p.e63103

2013

Volltextzugriff (PDF)

Antifungal photodynamic therapy

Microbiological research, 2008-01, Vol.163 (1), p.1-12

2008

Volltextzugriff (PDF)

Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: A systematic review

Journal of cystic fibrosis, 2019-03, Vol.18 (2), p.236-243

2019

Volltextzugriff (PDF)

CORK Study in Cystic Fibrosis: Sustained Improvements in Ultra-Low-Dose Chest CT Scores After CFTR Modulation With Ivacaftor

Chest, 2018-02, Vol.153 (2), p.395-403

2018

Volltextzugriff (PDF)

Diminished airway host innate response in people with cystic fibrosis who experience frequent pulmonary exacerbations

The European respiratory journal, 2024-02, Vol.63 (2), p.2301228

2024

Volltextzugriff (PDF)

Lung Clearance Index in Adults and Children With Cystic Fibrosis

Chest, 2016-12, Vol.150 (6), p.1323-1332

2016

Volltextzugriff (PDF)

Interspecific small molecule interactions between clinical isolates of Pseudomonas aeruginosa and Staphylococcus aureus from adult cystic fibrosis patients

PloS one, 2014-01, Vol.9 (1), p.e86705

2014

Volltextzugriff (PDF)

Interventions to Improve Antimicrobial Stewardship for Older People in Care Homes: A Systematic Review

Drugs & aging, 2019-04, Vol.36 (4), p.355-369

2019

Volltextzugriff (PDF)

1 – 25 von 212

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(201)
Mit Volltextzugriff
(198)

Publikationsform

Sprache

Englisch
(211)
Japanisch
(22)

Erscheinungsjahr

n.n

Thema

Science & Technology
(168)
Life Sciences & Biomedicine
(123)
Humans
(115)
Cystic Fibrosis
(66)
Microbiology
(53)
Female
(45)
Male
(43)
Antibiotics
(39)
Respiratory System
(38)
Adult
(36)
Cystic Fibrosis - Microbiology
(36)
Pseudomonas Aeruginosa
(35)
Bacteria
(32)
Pharmacology & Pharmacy
(29)
Biological And Medical Sciences
(28)
Anti-Bacterial Agents - Pharmacology
(27)
Science & Technology - Other Topics
(26)
Aged
(25)
Middle Aged
(25)
Multidisciplinary Sciences
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Long-term therapy with elexacaftor/tezacaftor/ivacaftor (ETI) in cystic fibrosis: improved clinical outcomes but infection and inflammation persist

The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations

Comparison of microbiomes from different niches of upper and lower airways in children and adolescents with cystic fibrosis

Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis

Fusobacterium nucleatum: a novel immune modulator in breast cancer?

Anaerobic bacteria cultured from cystic fibrosis airways correlate to milder disease: a multisite study

Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease

Reduced bacterial colony count of anaerobic bacteria is associated with a worsening in lung clearance index and inflammation in cystic fibrosis

Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations

Characterization of Bacteria Using Surface-Enhanced Raman Spectroscopy (SERS): Influence of Microbiological Factors on the SERS Spectra

The Role of Short-Chain Fatty Acids, Produced by Anaerobic Bacteria, in the Cystic Fibrosis Airway

Lung function and microbiota diversity in cystic fibrosis

Electronic cigarette vapour increases virulence and inflammatory potential of respiratory pathogens

Lung Microbiota and Bacterial Abundance in Patients with Bronchiectasis when Clinically Stable and during Exacerbation

Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo

Investigation of the effect of type 2 diabetes mellitus on subgingival plaque microbiota by high-throughput 16S rDNA pyrosequencing

Impact of the CFTR-potentiator ivacaftor on airway microbiota in cystic fibrosis patients carrying a G551D mutation

Significance of anaerobes and oral bacteria in community-acquired pneumonia

Antifungal photodynamic therapy

Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: A systematic review

CORK Study in Cystic Fibrosis: Sustained Improvements in Ultra-Low-Dose Chest CT Scores After CFTR Modulation With Ivacaftor

Diminished airway host innate response in people with cystic fibrosis who experience frequent pulmonary exacerbations

Lung Clearance Index in Adults and Children With Cystic Fibrosis

Interspecific small molecule interactions between clinical isolates of Pseudomonas aeruginosa and Staphylococcus aureus from adult cystic fibrosis patients

Interventions to Improve Antimicrobial Stewardship for Older People in Care Homes: A Systematic Review

Suchergebnisse filtern